Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

This registry is for people with Myotonic Dystrophy (DM) or Facioscapulohumeral Muscular Dystrophy (FSHD), or unaffected family members of someone with these conditions. It aims to connect you with researchers studying these inherited disorders, which cause progressive muscle weakness. By joining, you'll have the opportunity to participate in research focused on DM and FSHD. The main goal is to understand how your symptoms change over time, which will help scientists learn more about these diseases and share their findings with patients and healthcare providers. This registry is currently open for enrollment and plans to include 3000 participants.

Study design
This is an observational study, meaning researchers will collect information about your health over time without providing any specific treatment. It aims to enroll 3000 participants.
What's involved
You would complete an application packet, which includes a patient information form, a medical records release form, and an informed consent form. After enrolling, you would complete an annual update form to track changes in your symptoms.
Compensation
Not stated in the trial record.
Follow-up
You would complete an annual update form to help track how your symptoms change over time.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00082108

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Recruiting
Not specifiedAll AgesObservational
University of Rochester
~3,000 participants
Updated 2025-10-15 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient reported outcomes
Measured over Annual
Myotonic Dystrophy
Facioscapulohumeral Muscular Dystrophy
Muscular Dystrophy
Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 2
Congenital Myotonic Dystrophy
PROMM (Proximal Myotonic Myopathy)
Steinert's Disease
Myotonic Muscular Dystrophy
1 sites across 1 states
New York1
  • Johann Hamel, MD · PRINCIPAL_INVESTIGATOR · University of Rochester Medical Center, Department of Neurology

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosed with DM, FSHD, or related diseases or are an unaffected family member of someone diagnosed with one of these diseases
  • Patient reported outcomesAnnual